Results 191 to 200 of about 30,373 (294)

A Masked Intruder: Extranodal Natural Killer/T-Cell Lymphoma Mimicking Preseptal Cellulitis. [PDF]

Mayo Clin Proc Innov Qual Outcomes
Fuentes SA, Griepentrog GJ, King RL, Bennani NN, Chesdachai S.   +4 more
europepmc   +1 more source

Screening anticancer peptides performance in organotypic prostate tumor‐stroma 3D models

International Journal of Cancer, EarlyView.
What's New? Peptide‐based drugs have emerged as promising anticancer therapies for their potential to disrupt protein–protein interactions. In this study, the authors developed a physiomimetic human 3D prostate cancer spheroid model to assess the efficacy of the CAVPENET peptide in inhibiting tumor growth. Upon incubation with CAVPENET, prostate cancer
Bárbara Matos, Maria V. Monteiro, Matilde R. Lagarto, John Howl, Carmen Jerónimo, Vítor M. Gaspar, João F. Mano, Margarida Fardilha   +7 more
wiley   +1 more source

Explainable machine learning to identify chronic lymphocytic leukemia and medication use based on gut microbiome data. [PDF]

Microbiol Spectr
Fait Kadlec T, Ilett EE, da Cunha-Bang C, Sengeløv H, Brieghel C, Gulay A, Rafiq S, Ravn HB, Zheng C, Nielsen RV, Sørensen SS, Zargari Marandi R, Niemann CU.   +12 more
europepmc   +1 more source

Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms

iNew Medicine, EarlyView.
This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li, Xu Liu, Xin Ye, Zhixia Dong, Xinjian Wan   +4 more
wiley   +1 more source

Fatal hemoptysis despite complete remission of squamous cell carcinoma after chemoradiotherapy followed by combined ipilimumab and nivolumab: An autopsy case report. [PDF]

Medicine (Baltimore)
Horie K, Nakayama S, Hoshino A, Okada M, Terai H, Suzuki Y, Asakura T.   +6 more
europepmc   +1 more source

Cell Toxicity and Autophagy in A549 Cells Treated With Surface‐Functionalized Graphene Derivatives

Journal of Applied Toxicology, EarlyView.
ABSTRACT Graphene oxide and its derivatives have unique physical and chemical properties with applications in many different fields. However, their biological effects and mechanisms of intracellular toxicity have not been completely clarified. In this study, we investigated the cytotoxic and autophagic activities of graphene oxide and its derivatives ...
Tae Yun Park, Soo Young Kim, Chang Seok Park, Won Young Kim, Jae‐Woo Jung, Jae‐Yeol Kim, Jong Wook Shin   +6 more
wiley   +1 more source

Repurposing cephalosporins as excellent anticancer agents and chemosensitizers for inflammation-driven cancer therapy. [PDF]

Sci Rep
Liu N, Cao W, Tang J, Dong R, Guo J, Luo Z, Yao Q, Teng S, Liang Z, Yang Y, Gu M, Zhou J, Chen W, Liang H, He X.   +14 more
europepmc   +1 more source

Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly. [PDF]

, 2010
ABBADESSA, Vincenzo, Fazio, G, Guarneri, GP, Malato, A, RASO, Simona, RUSSO, Antonio, Saccullo, G, SIRAGUSA, Sergio, Vergara, B   +8 more
core   +1 more source

Is Micronucleus Assay a Suitable Biomarker for Evaluating the Cancer Risk in Professionals Exposed to Antineoplastic Drugs? A Systematic Review

Journal of Applied Toxicology, EarlyView.
ABSTRACT The widespread use of antineoplastic drugs in cancer treatment has led to significant concerns regarding the potential health risks posed to healthcare professionals involved in the preparation, administration, and handling of these chemical compounds, including genotoxicity.
Thiago Guedes Pinto, Lorrany da Silva Avanci, Gabriel Carvalhal de Aguiar, Daniel Vitor de Souza, Patricia Ramos Cury, Ana Claudia Muniz Renno, Daniel Araki Ribeiro   +6 more
wiley   +1 more source

Severe drug-associated anaphylaxis: a complementary descriptive analyses of registry cases and spontaneous reports. [PDF]

Eur J Clin Pharmacol
Christ P, Dubrall D, Dölle-Bierke S, Francuzik W, Schmid M, Sachs B, Worm M.   +6 more
europepmc   +1 more source